In vivo cell reprogramming. A major step forward in regenerative medicine

Cell reprogramming  is revolutionizing the biomedical world, not only because it can obtain cells of different tissues from pluripotent cells, but also because these cells can be genetically modified to be used for the treatment of serious illnesses or to better understand them,...

For now, iPS cells have revolutionized the laboratory bench more than bedside

In a recent article, Amélie Rezza discussed the current use of iPS cells, understanding as such adult cells reprogrammed following a technique discovered by Yamanaka. See HERE our site for furthermore information. After the development of these cells, it was thought that they...

Stem cell research. The two sides of the coin

Science facing market The “heads” of stem cell research Stem cells today represent a great hope for the future of regenerative medicine due to their ability to differentiate into cell lines of almost any tissue, making them a promising therapeutic option for many...

Human cryopreservation. Technique and ethical and moral assessment

There may be an insurmountable difficulty in relation to the revival of the cryopreserved cadaver Cryopreservation consists of preserving human individuals or organs at very low temperatures (less than -130°) in order to preserve them. The low temperatures decrease the metabolism...

Ethical reflection on the latest biomedical experiments by Juan Carlos Izpisua and his group

Over the last few days, some of the biomedical experiments conducted by Juan Carlos Izpisua and his group — in which researchers from several Spanish universities take part — have been widely reported by various media. Let us say at the outset that we see no need to highlight the...

Reduced the risk of infection by iPS cells when transplanted

Another major advance in cell reprogramming and in obtaining iPS cells was achieved by researchers at Osaka and Kyoto universities, led by Masoto Nakagawa and Shinya Yamanaka, who succeeded in developing a method by which the cells generated have a lower risk of infection when...
Posted On 04 Jul 2014
, By

Adult cells reprogramming technique (iPS) has been improved

One problem in reprogramming adult cells, using the technique proposed by Yamanaka in 2006, is that the percentage of cells reprogrammed is low, and not all are reprogrammed at the same time. Now, it appears that this problem has been resolved, after Israeli scientists developed...
Posted On 04 Jul 2014
, By

Significant step forward in the use of iPS cells in human clinical applications

As our readers are well aware, in 2006 Jun Takahashi and Shinya Yamanaka perfected a technique known as cellular reprogramming, which produces undifferentiated cells (iPS cells) from differentiated adult cells. These cells are similar to the embryonic cells. From these iPS cells...
Posted On 05 Mar 2014
, By

This news will no doubt create new hope in the therapeutic use of iPS cells in humans

The therapeutic possibilities offered by iPS cells seem self-evident and are set to increase thanks to the Japanese government’s commitment to promoting research in this field. Indeed, according to an article in Nature Biotechnology (31; 272-273, 2013), Japan plans to build a 222...
Posted On 29 Dec 2013
, By

Japan promote research with iPS cells

The therapeutic possibilities offered by iPS cells seem unquestionable, and may increase with the commitment of the Japanese government to promote research using them. Indeed, according to an article in Nature Biotechnology (31; 272-273, 2013), the Japanese government are going...
Posted On 13 Jun 2013
, By